ZANGRILLI, ARIANNA
 Distribuzione geografica
Continente #
NA - Nord America 5.448
AS - Asia 674
EU - Europa 578
SA - Sud America 125
AF - Africa 12
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 1
Totale 6.844
Nazione #
US - Stati Uniti d'America 5.414
SG - Singapore 292
CN - Cina 172
BR - Brasile 111
IT - Italia 91
IE - Irlanda 86
DE - Germania 84
HK - Hong Kong 73
SE - Svezia 70
RU - Federazione Russa 54
UA - Ucraina 52
GB - Regno Unito 51
FR - Francia 38
VN - Vietnam 28
IN - India 25
CA - Canada 24
KR - Corea 17
FI - Finlandia 14
UZ - Uzbekistan 14
MX - Messico 10
PL - Polonia 9
BD - Bangladesh 8
AR - Argentina 7
KG - Kirghizistan 7
AU - Australia 6
ES - Italia 6
JP - Giappone 6
RO - Romania 6
TR - Turchia 6
IQ - Iraq 5
NL - Olanda 5
JO - Giordania 4
ZA - Sudafrica 4
BE - Belgio 3
EG - Egitto 3
ID - Indonesia 3
MA - Marocco 3
MY - Malesia 3
AT - Austria 2
CH - Svizzera 2
CL - Cile 2
DK - Danimarca 2
EC - Ecuador 2
PK - Pakistan 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
BG - Bulgaria 1
DZ - Algeria 1
EU - Europa 1
IL - Israele 1
IR - Iran 1
KE - Kenya 1
KH - Cambogia 1
MD - Moldavia 1
NP - Nepal 1
OM - Oman 1
PE - Perù 1
PH - Filippine 1
PS - Palestinian Territory 1
PY - Paraguay 1
SA - Arabia Saudita 1
VE - Venezuela 1
Totale 6.844
Città #
Wilmington 1.475
Houston 1.173
Woodbridge 1.101
Fairfield 222
Chandler 196
Singapore 166
Ashburn 159
Ann Arbor 104
Seattle 89
Cambridge 85
Dublin 81
Beijing 77
Hong Kong 70
Medford 61
New York 52
Dearborn 45
Jacksonville 42
The Dalles 37
Los Angeles 32
Lawrence 28
Santa Clara 26
Rome 21
Council Bluffs 20
Zhengzhou 18
Dallas 16
San Diego 16
Buffalo 15
Brooklyn 13
Moscow 13
Munich 12
Ho Chi Minh City 11
Shanghai 11
Boardman 10
Chennai 10
São Paulo 10
Milan 9
Montreal 9
Denver 8
Hefei 8
Redondo Beach 8
Seoul 8
Warsaw 8
Atlanta 7
Brasília 7
Hanoi 7
Menlo Park 7
Norwalk 7
Redmond 7
Redwood City 7
London 6
Nuremberg 6
Stockholm 6
Tokyo 6
Toronto 6
Ankara 5
Belo Horizonte 5
Bologna 5
Chicago 5
Esslingen am Neckar 5
Mexico City 5
Orem 5
Rio de Janeiro 5
San Francisco 5
Sydney 5
Amman 4
Kilburn 4
Lappeenranta 4
Nanjing 4
Palo Alto 4
Poplar 4
Raleigh 4
Sedico 4
Augusta 3
Baghdad 3
Boston 3
Brussels 3
Detroit 3
Genazzano 3
Guangzhou 3
Jinan 3
Mülheim 3
Nanchang 3
Paris 3
Phoenix 3
Aprilia 2
Bari 2
Biên Hòa 2
Cairo 2
Central 2
Charlotte 2
Chevy Chase 2
City of London 2
Coimbatore 2
Concord 2
Engelhard 2
Falls Church 2
Feira de Santana 2
Florence 2
Florianópolis 2
Fuzhou 2
Totale 5.804
Nome #
Efficacy and Safety of Subcutaneous Anti-Tumor Necrosis Factor-Alpha Agents, Etanercept and Adalimumab, in Elderly Patients Affected by Psoriasis and Psoriatic Arthritis: An Observational Long-Term Study 456
Adalimumab for severe psoriasis and psoriatic arthritis: an open-label study in 30 patients previously treated with other biologics 435
Adalimumab in the treatment of plaque-type psoriasis and psoriatic arthritis 427
HLA-C*06:02 Does Not Predispose to Clinical Response Following Long-Term Adalimumab Treatment in Psoriatic Patients: A Retrospective Cohort Study. 420
Real-life 9-year experience with adalimumab in psoriasis and psoriatic arthritis: results of a single-centre, retrospective study. 406
TNF-α antagonists and nail psoriasis: An open, 24-week, prospective cohort study in adult patients with psoriasis 380
Erysipeloid cutaneous metastasis from bladder carcinoma 376
Quality of life of psoriatic patients evaluated by a new psychometric assessment tool: PsoDisk 376
Long-term treatment of psoriatic patients with adalimumab reduces disease severity and maintains a favorable lipid pattern and a low Atherogenic Index. 354
Use of biological drugs in patients with psoriasis and psoriatic arthritis in Italy: Results from the PSONG survey 322
Radiologically significant joint improvement in a patient affected by psoriatic arthritis treated with adalimumab 302
Efficacy and safety of adalimumab after failure of other anti-TNFα agents for plaque-type psoriasis: clinician behavior in real life clinical practice 255
Paradoxical case effects of psoriasis following adalimumab therapy: A case series 254
Adalimumab in severe plaque psoriasis of childhood: A multi-center, retrospective real-life study up to 52 weeks observation 242
One drug and two diseases: A case of multidrug-resistant hidradenitis suppurativa and psoriasis treated with apremilast 229
Real life experience of apremilast in psoriasis and arthritis psoriatic patients: preliminary results on metabolic biomarkers 179
Adalimumab in children and adolescents with severe plaque psoriasis: a safety evaluation 177
Efficacy and safety of Adalimumab in difficult-to-treat psoriasis 173
Detection of adalimumab and anti-adalimumab levels by ELISA: clinical considerations 159
Ixekizumab: One drug for an enigmatic psoriasis 121
Psoriasis in difficult to treat areas: treatment role in improving health-related quality of life and perception of the disease stigma 120
Adalimumab for moderate to severe psoriasis: an open-label, retrospective 3-year study 114
Omalizumab and adalimumab: a winning couple 113
A linear forehead lesion caused by intralesional injection of triamcinolone acetonide and treated with hyaluronic acid filler: case report 107
Risankizumab: How to choose the right dose in clinical practice? 92
Clinical severity instruments 89
Paradoxical psoriasis induced by anti-TNFα treatment: evaluation of disease-specific clinical and genetic markers 87
Long-term efficacy of adalimumab in generalized pustular psoriasis 83
Effectiveness of risankizumab for the treatment of psoriatic arthritis: a multicenter, real‐world study 69
Improvement of Psoriasis Using Oral Probiotic Streptococcus salivarius K-12: a Case–Control 24-Month Longitudinal Study 44
Effectiveness of risankizumab in the treatment of palmoplantar psoriasis: A 52-week Italian real-life experience 42
Effectiveness of ixekizumab in elderly patients for the treatment of moderate-to-severe psoriasis: results from a multicenter, retrospective real-life study in the Lazio region 33
null 3
Totale 7.039
Categoria #
all - tutte 20.251
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.251


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021641 0 0 0 0 0 179 168 152 43 42 34 23
2021/2022322 15 30 21 25 10 18 17 12 18 50 19 87
2022/2023439 35 51 23 53 36 95 37 22 45 13 15 14
2023/2024148 14 3 8 5 18 29 12 23 4 9 0 23
2024/2025624 27 119 92 27 6 36 66 28 50 62 69 42
2025/2026647 126 50 146 145 134 46 0 0 0 0 0 0
Totale 7.039